These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. In vivo ultrasound molecular imaging of inflammatory thrombosis in arteries with cyclic Arg-Gly-Asp-modified microbubbles targeted to glycoprotein IIb/IIIa. Wu W; Wang Y; Shen S; Wu J; Guo S; Su L; Hou F; Wang Z; Liao Y; Bin J Invest Radiol; 2013 Nov; 48(11):803-12. PubMed ID: 23857134 [TBL] [Abstract][Full Text] [Related]
3. [Targeted adhesion of platelet receptor-specific microbubble agent to thrombus in vitro]. Ou WC; Xiu JC; Xie JG; Zha DG; Liu J; Hao R; Bin JP; Liu YL Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):672-4. PubMed ID: 15958305 [TBL] [Abstract][Full Text] [Related]
4. Enhancement of ultrasonic thrombus imaging using novel liposomal bubbles targeting activated platelet glycoprotein IIb/IIIa complex--in vitro and in vivo study. Hagisawa K; Nishioka T; Suzuki R; Takizawa T; Maruyama K; Takase B; Ishihara M; Kurita A; Yoshimoto N; Ohsuzu F; Kikuchi M Int J Cardiol; 2011 Oct; 152(2):202-6. PubMed ID: 20678821 [TBL] [Abstract][Full Text] [Related]
5. Dual targeting improves capture of ultrasound microbubbles towards activated platelets but yields no additional benefit for imaging of arterial thrombosis. Günther F; Heidt T; Kramer M; Khanicheh E; Klibanov AL; Geibel-Zehender A; Ferrante EA; Hilgendorf I; Wolf D; Zirlik A; Reinöhl J; Bode C; Peter K; Kaufmann BA; Mühlen CVZ Sci Rep; 2017 Nov; 7(1):14898. PubMed ID: 29097799 [TBL] [Abstract][Full Text] [Related]
6. [Preparation and preliminary evaluation of KGDS-targeted ultrasound contrast agent]. Gao F; Ding Y; Sheng X; Wang W; Liang Q; Luo Z; Zhou P; Li H Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Dec; 34(12):1255-60. PubMed ID: 20045923 [TBL] [Abstract][Full Text] [Related]
7. Novel single-chain antibody-targeted microbubbles for molecular ultrasound imaging of thrombosis: validation of a unique noninvasive method for rapid and sensitive detection of thrombi and monitoring of success or failure of thrombolysis in mice. Wang X; Hagemeyer CE; Hohmann JD; Leitner E; Armstrong PC; Jia F; Olschewski M; Needles A; Peter K; Ahrens I Circulation; 2012 Jun; 125(25):3117-26. PubMed ID: 22647975 [TBL] [Abstract][Full Text] [Related]
9. Grafting of abciximab to a microbubble-based ultrasound contrast agent for targeting to platelets expressing GP IIb/IIIa - characterization and in vitro testing. Della Martina A; Allémann E; Bettinger T; Bussat P; Lassus A; Pochon S; Schneider M Eur J Pharm Biopharm; 2008 Mar; 68(3):555-64. PubMed ID: 17884399 [TBL] [Abstract][Full Text] [Related]
11. Molecular imaging of human thrombus with novel abciximab immunobubbles and ultrasound. Alonso A; Della Martina A; Stroick M; Fatar M; Griebe M; Pochon S; Schneider M; Hennerici M; Allémann E; Meairs S Stroke; 2007 May; 38(5):1508-14. PubMed ID: 17379828 [TBL] [Abstract][Full Text] [Related]
12. Formation of Microbubbles for Targeted Ultrasound Contrast Imaging: Practical Translation Considerations. Unnikrishnan S; Du Z; Diakova GB; Klibanov AL Langmuir; 2019 Aug; 35(31):10034-10041. PubMed ID: 30509068 [TBL] [Abstract][Full Text] [Related]
13. Thrombus-Targeted Theranostic Microbubbles: A New Technology towards Concurrent Rapid Ultrasound Diagnosis and Bleeding-free Fibrinolytic Treatment of Thrombosis. Wang X; Gkanatsas Y; Palasubramaniam J; Hohmann JD; Chen YC; Lim B; Hagemeyer CE; Peter K Theranostics; 2016; 6(5):726-38. PubMed ID: 27022419 [TBL] [Abstract][Full Text] [Related]
14. Surface Modification with Lactadherin Augments the Attachment of Sonazoid Microbubbles to Glycoprotein IIb/IIIa. Otani K; Kamiya A; Miyazaki T; Koga A; Inatomi A; Harada-Shiba M Ultrasound Med Biol; 2019 Jun; 45(6):1455-1465. PubMed ID: 30857759 [TBL] [Abstract][Full Text] [Related]
15. Targeted ultrasound contrast agent for molecular imaging of inflammation in high-shear flow. Klibanov AL; Rychak JJ; Yang WC; Alikhani S; Li B; Acton S; Lindner JR; Ley K; Kaul S Contrast Media Mol Imaging; 2006; 1(6):259-66. PubMed ID: 17191766 [TBL] [Abstract][Full Text] [Related]
16. Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo. Guth BD; Seewaldt-Becker E; Himmelsbach F; Weisenberger H; Müller TH J Cardiovasc Pharmacol; 1997 Aug; 30(2):261-72. PubMed ID: 9269956 [TBL] [Abstract][Full Text] [Related]
17. In vitro measurement of platelet glycoprotein IIb/IIIa receptor blockade by abciximab: interindividual variation and increased platelet secretion. Rossi F; Rossi E; Pareti FI; Colli S; Tremoli E; Gallo L Haematologica; 2001 Feb; 86(2):192-8. PubMed ID: 11224490 [TBL] [Abstract][Full Text] [Related]
18. BR55: a lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis. Pochon S; Tardy I; Bussat P; Bettinger T; Brochot J; von Wronski M; Passantino L; Schneider M Invest Radiol; 2010 Feb; 45(2):89-95. PubMed ID: 20027118 [TBL] [Abstract][Full Text] [Related]
19. Preparation of thrombosis-targeted lipid microbubbles and determination of rabbit carotid artery thrombosis by microbubbles ultrasonogaphy. Xu WM; Feng M; Zhao HY; Xie MX; Li WY; Fu R J Huazhong Univ Sci Technolog Med Sci; 2013 Feb; 33(1):146-152. PubMed ID: 23392725 [TBL] [Abstract][Full Text] [Related]
20. Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy. Rapoport N; Gao Z; Kennedy A J Natl Cancer Inst; 2007 Jul; 99(14):1095-106. PubMed ID: 17623798 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]